ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Portfolio · X-ray

What your mutual funds really own

Add the funds you hold, and optionally how much you have in each. See the companies, sectors and company sizes your money ends up in when the funds are combined — including what you may own more of than you realise.

Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →

Your funds

1 of 8 chosen

FundAmount (₹, optional)Share of total
NIPPON INDIA PHARMA FUNDNippon India Mutual Fund · Sep 2026 100.0% Remove

Leave amounts blank to weigh the funds equally. Amounts stay in this page’s address and are not stored.

Portfolio summary

Your 1 fund combined, weighted by the amounts above.

Funds1In this X-ray
Unique underlying stocks360 held by more than one fund
Top 10 stock concentration57.9%Of your combined equity
Top 3 sector concentration95.0%Healthcare, Consumer Services
Highest fund overlapN/ANeeds two or more funds

6 stocks each make up more than 5% of your combined equity (Sun Pharmaceutical Industries Limited, Divi's Laboratories Limited, Lupin Limited, Cipla Limited and others). Healthcare is more than 25% of it. These are descriptions of the mix, not a view on it.

Biggest underlying exposures

Your largest stocks across all selected funds

  1. Sun Pharmaceutical Industries LimitedHealthcare · in 1 of your fund12.03%
  2. Divi's Laboratories LimitedHealthcare · in 1 of your fund7.30%
  3. Lupin LimitedHealthcare · in 1 of your fund6.34%
  4. Cipla LimitedHealthcare · in 1 of your fund6.18%
  5. Dr. Reddy's Laboratories LimitedHealthcare · in 1 of your fund5.60%
  6. Apollo Hospitals Enterprise LimitedHealthcare · in 1 of your fund5.02%
  7. Mankind Pharma LimitedHealthcare · in 1 of your fund4.50%
  8. Sai Life Sciences LimitedHealthcare · in 1 of your fund4.03%
  9. Ajanta Pharma LimitedHealthcare · in 1 of your fund3.71%
  10. GlaxoSmithKline Pharmaceuticals LimitedHealthcare · in 1 of your fund3.20%
  11. IPCA Laboratories LimitedHealthcare · in 1 of your fund2.95%
  12. Max Healthcare Institute LimitedHealthcare · in 1 of your fund2.77%
  13. Vijaya Diagnostic Centre LimitedHealthcare · in 1 of your fund2.69%
  14. Medplus Health Services LimitedConsumer Services · in 1 of your fund2.60%
  15. Gland Pharma LimitedHealthcare · in 1 of your fund2.60%

Sector exposure

Combined effective sector weights · NSE industry

Size mix: Large Cap 38.9% · Mid Cap 28.0% · Small Cap 32.5% · Not in AMFI list 0.6%.

Every company you own through these funds

36 companies · largest first

CompanySectorSizeYour exposureIn your funds
Sun Pharmaceutical Industries Limited Healthcare Large Cap 12.03% 1
Divi's Laboratories Limited Healthcare Large Cap 7.30% 1
Lupin Limited Healthcare Mid Cap 6.34% 1
Cipla Limited Healthcare Large Cap 6.18% 1
Dr. Reddy's Laboratories Limited Healthcare Large Cap 5.60% 1
Apollo Hospitals Enterprise Limited Healthcare Large Cap 5.02% 1
Mankind Pharma Limited Healthcare Mid Cap 4.50% 1
Sai Life Sciences Limited Healthcare Small Cap 4.03% 1
Ajanta Pharma Limited Healthcare Small Cap 3.71% 1
GlaxoSmithKline Pharmaceuticals Limited Healthcare Mid Cap 3.20% 1
IPCA Laboratories Limited Healthcare Mid Cap 2.95% 1
Max Healthcare Institute Limited Healthcare Large Cap 2.77% 1
Vijaya Diagnostic Centre Limited Healthcare Small Cap 2.69% 1
Medplus Health Services Limited Consumer Services Small Cap 2.60% 1
Gland Pharma Limited Healthcare Small Cap 2.60% 1
Abbott India Limited Healthcare Mid Cap 2.39% 1
Piramal Pharma Limited Healthcare Small Cap 2.30% 1
Thyrocare Technologies Limited Healthcare Small Cap 2.30% 1
Dr. Lal Path Labs Ltd. Healthcare Small Cap 2.23% 1
Alkem Laboratories Limited Healthcare Mid Cap 1.87% 1
Aurobindo Pharma Limited Healthcare Mid Cap 1.69% 1
Narayana Hrudayalaya Ltd. Healthcare Mid Cap 1.65% 1
Suraksha Diagnostic Limited Not classified Small Cap 1.55% 1
Syngene International Limited Healthcare Small Cap 1.43% 1
Emcure Pharmaceuticals Limited Healthcare Small Cap 1.40% 1
Pfizer Limited Healthcare Small Cap 1.38% 1
Akums Drugs and Pharmaceuticals Limited Healthcare Small Cap 1.24% 1
Anthem Biosciences Limited Healthcare Mid Cap 1.23% 1
Fortis Healthcare Limited Healthcare Mid Cap 1.16% 1
Biocon Limited Healthcare Mid Cap 1.04% 1
Sanofi India Limited Not classified Small Cap 1.03% 1
Sanofi Consumer Healthcare India Limited Not classified Small Cap 0.91% 1
Molbio Diagnostics Limited Not classified — 0.56% 1
Indoco Remedies Limited Not classified Small Cap 0.49% 1
AstraZeneca Pharma India Limited Not classified Small Cap 0.43% 1
Concord Biotech Limited Healthcare Small Cap 0.17% 1

Each fund’s amount is treated as spread like its latest disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are left out, so for hybrid, debt or international funds only the Indian equity part is shown. Portfolios change every month. This is a description, not advice. Method →